XML 129 R93.htm IDEA: XBRL DOCUMENT v3.21.2
INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Finance results (Details) - USD ($)
12 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2019
Finance Costs      
Interest expenses with the Parents $ (1,219,776) $ (1,861,774) $ (1,386,288)
Interest expenses (17,702,770) (17,535,324) (20,450,254)
Financial commissions (2,317,690) (1,483,428) (1,578,292)
Finance Costs (21,240,236) (20,880,526) (23,414,834)
Other finance results      
Exchange differences generated by assets 22,161,855 30,194,601 48,355,784
Exchange differences generated by liabilities (35,541,048) (50,815,215) (66,200,973)
Changes in fair value of financial assets or liabilities and other financial results (5,057,589) (418,186) (540,589)
Gain from cancellation of purchase option     6,582,849
Share-based payment cost of listing shares     (20,893,789)
Net gain of inflation effect on monetary items 11,824,678 9,216,684 14,653,335
Other finance results (6,612,104) (11,822,116) (18,043,383)
Total net finance results (27,852,340) (32,702,642) (41,458,217)
Profit from translation effects 10,076,208 (10,108,444) 5,240,151
Rizobacter Argentina S.A      
Other finance results      
Profit from translation effects $ 6,700,000 $ 3,600,000 $ 1,200,000